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Résumé en
anglais
Human cystic echinococcosis is a zoonosis caused by the larval stage of the tapeworm
Echinococcus granulosus sensu lato (s. l.). Although benzimidazole compounds such as
albendazole (ABZ) and mebendazole have been the cornerstone of chemotherapy for
the disease, there is often no complete recovery after treatment. Hence, new strategies
are required to improve treatment of human cystic echinococcosis. The goals of the
current study were as follows: (i) to evaluate the in vitro efficacy of the 5-fluorouracil
(5-FU) and ABZ combination against E. granulosus s. l. protoscoleces and cysts, (ii) to
compare the clinical efficacy of 5-FU alone or in combination with ABZ in infected
mice. The combination of 5-FU +ABZ had a stronger in vitro effect against larval stage
than that did both drugs alone. Even at the lowest concentration of 5-FU +ABZ
combination (1 μg/ml), the reduction of the viability of protoscoleces and cysts was
greater than that observed with drugs alone at 10 μg/ml. The results were confirmed at
the ultrastructural level by scanning electron microscopy. These data helped to justify
the in vivo investigations assessing the therapeutic potential of the combination of 5-
FU and ABZ suspension in CF-1 mice infected with E. granulosus sensu stricto (s. s.)
metacestodes. Treatment with 5-FU (10 mg/kg) or 5-FU (10 mg/kg) + ABZ suspension
(5 mg/kg) reduced the weight of cysts recovered from mice compared with control
groups. Interestingly, the effect of 5-FU given weekly for 5 consecutive weeks was
comparable to that observed with ABZ suspension under a daily schedule during 30
days. Co-administration of 5-FU with ABZ did not enhance the in vivo efficacy of drugs
alone calculated in relation to cysts weights. However, the combination provoked
greater ultrastructural alterations compared to the monotherapy. In conclusion, we
demonstrated the efficacy of 5-FU either alone or co-administrated with ABZ against
murine experimental cystic echinococcosis.
Since 5-FU treatments did not cause toxic effect in mice, further in vivo studies will be
performed by adjusting the dosage and the frequency of treatments.
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